Ross M Kedl

USPTO Granted Patents = 14 (Patent Applications = 7)

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 3.2

ph-index = 8

Forward Citations = 398(Granted Patents)

Location History:

Roseville, MN (US) (1994 - 2012)
Denver, CO (US) (2015)
Centennial, CO (US) (2011 - 2019)

Company Filing History:

6 out of 14,073

3m Innovative Properties Company

University of Colorado

patents

4. 1 out of 7,865

Minnesota Mining and Manufacturing Company

patents

where one patent can have more than one assignee

Years Active: 1994-2019

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10329338 - Nucleic acid construct encoding an agonistic anti-CD40 antibody and a type I interferon (2019-06-25),

2. 10105426 - Immunostimulatory combinations (2018-10-23),

3. 9801947 - Methods and compositions for enhancing immune response (2017-10-31),

4. 9161976 - Immunotherapy comprising TLR9 ligand and CD40 ligand (2015-10-20),

5. 9095608 - Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD40 antibody (2015-08-04),

6. 8961477 - Delivery of immune response modifier compounds (2015-02-24),

7. 8361471 - Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD40 antibody (2013-01-29),

8. 8329197 - Ex vivo uses of immunostimulatory combinations (2012-12-11),

9. 8137672 - Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD40 antibody (2012-03-20),

10. 7993659 - TLR9 agonist and CD40 agonist immunostimulatory combinations (2011-08-09),

11. 7993648 - Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD40 antibody (2011-08-09),

12. 7427629 - Immunostimulatory compositions and methods of stimulating an immune response (2008-09-23),

13. 7387271 - Immunostimulatory combinations (2008-06-17),

14. 5326598 - Electrospray coating apparatus and process utilizing precise control of (1994-07-05),

Title: Ross M Kedl: Innovator in Immunology

Introduction

Ross M Kedl is a prominent inventor based in Roseville, MN (US). He has made significant contributions to the field of immunology, holding a total of 14 patents. His work focuses on developing innovative solutions for enhancing immune responses and improving vaccine efficacy.

Latest Patents

Among his latest patents is a nucleic acid construct encoding an agonistic anti-CD40 antibody and a type I interferon. This synergistic adjuvant comprises effective amounts of at least one type 1 interferon and at least one CD40 agonist, which may be in the same or separate compositions. Additionally, he has developed fusion proteins and DNA conjugates that contain a type 1 interferon/CD40 agonist/antigen combination. These compositions are designed to serve as immune adjuvants for treating various chronic diseases, such as HIV infection, and for enhancing the efficacy of both prophylactic and therapeutic vaccines. Another notable invention involves immunostimulatory combinations that include a TLR agonist and a TNF/R agonist, with some combinations also incorporating an antigen.

Career Highlights

Ross M Kedl has worked with notable organizations, including 3M Innovative Properties Company and Dartmouth College. His career has been marked by a commitment to advancing immunological research and developing practical applications for his inventions.

Collaborations

Throughout his career, Ross has collaborated with esteemed colleagues, including Randolph J Noelle and Cory L Ahonen. These partnerships have contributed to the success and impact of his innovative work.

Conclusion

Ross M Kedl is a distinguished inventor whose contributions to immunology have the potential to transform treatment approaches for chronic diseases and enhance vaccine effectiveness. His ongoing research and patent portfolio reflect his dedication to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.